|
- 2017
六磷酸肌醇对人骨肉瘤细胞株MG-63和原代培养成骨细胞增殖的影响
|
Abstract:
摘要:目的 研究六磷酸肌醇(inositol hexaphosphate, IP6)对人骨肉瘤细胞株MG-63和原代培养成骨细胞增殖的影响,并探求其抗癌效果的最佳作用浓度。方法 原代培养人成骨细胞并鉴定,复苏并常规培养人骨肉瘤细胞株??MG-63??,MTT法检测不同浓度IP??6干预培养时两种细胞的增殖情况,确定IP6的最佳抑癌浓度,并进一步用流式细胞仪检测MG-63细胞周期及凋亡情况。结果 当IP6浓度≥1mmol/L时开始抑制MG-63细胞增殖,在4mmol/L时达到最大,并呈时间-剂量依赖性;当IP6浓度为0.5、1mmol/L时,对成骨细胞增殖抑制不明显,2mmol/L时轻度抑制,4mmol/L时导致成骨细胞凋亡。结论 IP6能够抑制人骨肉瘤细胞MG-63的增殖并导致其凋亡,其抗癌的最佳作用浓度为2mmol/L。
ABSTRACT: Objective To investigate the effects of inositol hexaphosphate (IP6) on proliferation of human osteosarcoma cell line MG-63 and primary cultured osteoblasts so as to explore the optimal concentration for achieving anti-cancer effects. Methods We primary cultured and identified human osteoblasts. Then we made recovery and normal culture of human osteosarcoma cell line MG-63. We tested the proliferation of two kinds of cell lines under different concentrations of IP6 by MTT to determine the optimal concentration and then detected MG-63 cell cycle and apoptosis by flow cytometry. Results When IP6 concentration was more than 1mmol/L, IP6 began to inhibit the proliferation of MG-63 cell line in the time-dose dependent manner. When the concentration reached 4mmol/L, this inhibitory effect was the maximum. When IP6 concentration was 0.5mmol/L or 1mmol/L, the proliferation of osteoblasts was not obviously inhibited. When it was 2 mmol/L, the proliferation was slightly inhibited. A concentration of 4mmol/L caused the apoptosis of osteoblasts. Conclusion IP6 can inhibit the proliferation of osteosarcoma cell line MG-63 and lead to its apoptosis. The optimal concentration is 2mmol/L for achieving anti-cancer effects
[1] | BACCI G, ROCCA M, SALONE M, et al. High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions[J]. J Surg Oncol, 2008, 98(6):415-420. |
[2] | NAWROCKA-MUSIAL D, LATOCHA M. Phytic acid-anticancer nutriceutic[J]. Pol Merkur Lekarski, 2012, 33(193):43-47. |
[3] | 付敏,宋扬,李馨. 肌醇六磷酸和肌醇联合应用对结直肠癌肝转移血管生成因子的影响[J]. 营养学报, 2016, 38(2):166-171. |
[4] | CAUDILL JS, ARNDT CA. Diagnosis and management of bone malignancy in adolescence[J]. Arch Pediat Adol Med, 2007, 18(1):62-78. |
[5] | SIEGEL RL, MILLER KD, JEMAL A. Cancer statistics[J]. CA-Cancer J Clin, 2015, 64(1):5-29. |
[6] | SOMASUNDAR P, RIGGS DR, JACKSON BJ, et al. Inositol hexaphosphate (IP<sub>6</sub>): A novel treatment for pancreatic cancer[J]. J Surg Res, 2004, 121(2):199-203. |
[7] | SCHROTEROCA L, HASKOVA P, RUDOLF E, et al. Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma[J]. Oncol Rep, 2010, 23(3):787-793. |
[8] | MARKS G, AYDOS RD, FAGUNDES DJ, et al. Modulation of transforming growth factor beta2 (TGF-beta2) by inositol hexaphosphate in colon carcinogenesis in rats[J]. Acta Cir Bras, 2006, 21(4):51-56. |
[9] | VUCENIK I, SHAMSUDDIN AM. Protection against cancer by dietary IP<sub>6</sub> and inositol[J]. Nutr Cancer, 2006, 55(2):109-125. |
[10] | AGARWAL C, DHANALAKSHMI S, SINGH RP, et al. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells[J]. Cancer Res, 2004, 6(5):646-659. |
[11] | VUCENIK I, SHAMSUDDIN AM. Cancer inhibition by inositol hexaphosphate (IP<sub>6</sub>) and inositol: From laboratory to clinic[J]. J Nutr, 2003, 133(11):3778S-3784S. |
[12] | TANTIVEJKUL K, VUCENIK I, SHAM SUDDIN AM. Inositol hexaphosphate (IP<sub>6</sub>) inhibits key events of cancermetastasis: II. Effects on integrins and focal adhesions[J]. Anticancer Res, 2003, 23(5A):3681-3689. |
[13] | FOX CH, EBERL M. Phytic acid (IP<sub>6</sub>), novel broad-spectrum anti-neoplastic agent: A systematic review[J]. Compl Ther Med, 2002, 10(4):229-234. |
[14] | SHAFIE NH, ESA NM, ITHNIN H, et al. Pro-apoptotic effect of rice bran inositol hexaphosphate (IP<sub>6</sub>) on HT-29 colorectal cancer cells[J]. Int J Mol Sci, 2013, 14(12):23545-23558. |